+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1



Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1



American Journal of Tropical Medicine and Hygiene 59(2): 307-311



Praziquantel is the drug of choice for schistosomiasis chemotherapy. Although the exact mechanism of how praziquantel kills schistosomes remains poorly understood, the immune response of the host is an important factor in drug efficacy. It is thus possible that disease states of humans that lead to immunodeficiencies, such as infection with human immunodeficiency virus-1 (HIV-1), may render praziquantel less effective in treating schistosomiasis. To test this hypothesis, persons with high levels of Schistosoma mansoni infection who were or were not also infected with HIV-1 were treated with a standard regimen of praziquantel and monitored by quantitative fecal examination and plasma circulating cathodic antigen. Both groups responded to praziquantel therapy equally and individuals with low percentages (< 20%) of CD4+ T cells did not differ from individuals with higher CD4 cell percentages. These data demonstrate that persons with HIV-1 infection can be treated effectively for schistosomiasis with praziquantel.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 003284239

Download citation: RISBibTeXText

PMID: 9715952


Related references

Interactions between schistosomiasis and human immunodeficiency virus in Western Kenya. Memorias do Instituto Oswaldo Cruz 99(5 Suppl 1): 93-95, 2004

Studies on schistosomiasis in western Kenya: I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. American Journal of Tropical Medicine and Hygiene 56(5): 515-521, 1997

Supplement 1. Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus || Quality Standard for the Identification and Treatment of Persons Coinfected with Human Immunodeficiency Virus and Mycobacterium tuberculosis. Clinical Infectious Diseases 21: S130-S131, 1995

Dual Efficacy of Lamivudine Treatment in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Persons in a Randomized, Controlled Study (Caesar). The Journal of Infectious Diseases 180(3): 607-613, 1999

Schistosomiasis and infection with human immunodeficiency virus 1 in rural Zimbabwe: systemic inflammation during co-infection and after treatment for schistosomiasis. American Journal of Tropical Medicine and Hygiene 79(3): 331-337, 2008

Comparative efficacy of levo-praziquantel and praziquantel in treatment of schistosomiasis japonica at a single dose. Chinese Medical Journal 104(9): 732-735, 1991

Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR). The CAESAR Coordinating Committee. Journal of Infectious Diseases 180(3): 607-613, 1999

Preliminary observations on the treatment of Schistosomiasis mansoni with praziquantel in Kenya. Arzneimittel-Forschung 31(3a): 594-596, 1981

Side effects of praziquantel in the treatment of urinary schistosomiasis in Kenya. Tropical Medicine 34(3): 91-96, 1992

Efficacy of praziquantel syrup versus crushed praziquantel tablets in the treatment of intestinal schistosomiasis in Ugandan preschool children, with observation on compliance and safety. Transactions of the Royal Society of Tropical Medicine and Hygiene 106(7): 400-407, 2012

Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis. Parasites and Vectors 4: 201, 2011

Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya. American Journal of Tropical Medicine and Hygiene 98(6): 1770-1781, 2018

A comparative trial of single dose treatment with praziquantel and levo praziquantel in human schistosomiasis japonica. Japanese Journal of Parasitology 37(5): 331-334, 1988

Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya. Tropical Medicine and International Health 14(4): 450-457, 2009

Efficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet. Infectious Diseases 16(2): 199-208, 2016